SLN-226

N/A

Report date: 2025/01/26 15:32:03
NME

Base Information

Drug NameSLN-226
Drug Alias NameGalNAc-conjugated siRNA therapeutic (Silence Therapeutics)SLN-226
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesSilence Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A